Method for diagnosing remyelination and regeneration processes of myelin in patients with diagnosed multiple sclerosis
Patent inventors: Katarzyna Konarzewska, Małgorzata Zawadzka

The subject of the present invention is a method for detecting active, remyelinating lesions in patients diagnosed with multiple sclerosis through the determination of changes in the levels of interleukin-33 in peripheral blood and cerebrospinal fluid, which constitutes a novel marker of endogenous repair processes facilitating the monitoring of the differentiation of oligodendrocyte precursor differentiation in patients.

Patent was granted in Poland and Nencki Institute is the sole applicant.

For more information contact Technology Transfer Office.

Application number:
P.415290 (14 Dec 2015), PCT/IB2015/002333 (14 Dec 2015)
Patent number:
PL235340 (02 Mar 2020)
Patent status: